PURPOSE: To examine longitudinal parent-reported social outcomes for children treated for pediatric embryonal brain tumors. PATIENTS AND METHODS: Patients (N=220) were enrolled onto a multisite clinical treatment protocol. Parents completed the Child Behavior Checklist/6-18 at the time of their child's diagnosis and yearly thereafter. A generalized linear mixed effects model regression approach was used to examine longitudinal changes in parent ratings of social competence, social problems, and withdrawn/depressed behaviors with demographic and treatment factors as covariates. RESULTS: During the 5-year period following diagnosis and treatment, few patients were reported to have clinically elevated scores on measures of social functioning. Mean scores differed significantly from population norms, yet remained within the average range. Several factors associated with unfavorable patterns of change in social functioning were identified. Patients with high-risk treatment status had a greater increase in parent-reported social problems (P=.001) and withdrawn/depressed behaviors (P=.01) over time compared with average-risk patients. Patients with posterior fossa syndrome had greater parent-reported social problems over time (P=.03). Female patients showed higher withdrawn/depressed scores over time compared with male patients (P<.001). Patient intelligence, age at diagnosis, and parent education level also contributed to parent report of social functioning. CONCLUSION: Results of this study largely suggest positive social adjustment several years after diagnosis and treatment of a pediatric embryonal tumor. However, several factors, including treatment risk status and posterior fossa syndrome, may be important precursors of long-term social outcomes. Future research is needed to elucidate the trajectory of social functioning as these patients transition into adulthood.
PURPOSE: To examine longitudinal parent-reported social outcomes for children treated for pediatric embryonal brain tumors. PATIENTS AND METHODS: Patients (N=220) were enrolled onto a multisite clinical treatment protocol. Parents completed the Child Behavior Checklist/6-18 at the time of their child's diagnosis and yearly thereafter. A generalized linear mixed effects model regression approach was used to examine longitudinal changes in parent ratings of social competence, social problems, and withdrawn/depressed behaviors with demographic and treatment factors as covariates. RESULTS: During the 5-year period following diagnosis and treatment, few patients were reported to have clinically elevated scores on measures of social functioning. Mean scores differed significantly from population norms, yet remained within the average range. Several factors associated with unfavorable patterns of change in social functioning were identified. Patients with high-risk treatment status had a greater increase in parent-reported social problems (P=.001) and withdrawn/depressed behaviors (P=.01) over time compared with average-risk patients. Patients with posterior fossa syndrome had greater parent-reported social problems over time (P=.03). Female patients showed higher withdrawn/depressed scores over time compared with male patients (P<.001). Patient intelligence, age at diagnosis, and parent education level also contributed to parent report of social functioning. CONCLUSION: Results of this study largely suggest positive social adjustment several years after diagnosis and treatment of a pediatric embryonal tumor. However, several factors, including treatment risk status and posterior fossa syndrome, may be important precursors of long-term social outcomes. Future research is needed to elucidate the trajectory of social functioning as these patients transition into adulthood.
Authors: Sundeep R Bhat; Tress L Goodwin; Tasha M Burwinkle; Meagan F Lansdale; Gary V Dahl; Stephen L Huhn; Iris C Gibbs; Sarah S Donaldson; Ruth K Rosenblum; James W Varni; Paul G Fisher Journal: J Clin Oncol Date: 2005-08-20 Impact factor: 44.544
Authors: Donald J Mabbott; Brenda J Spiegler; Mark L Greenberg; James T Rutka; Douglas J Hyder; Eric Bouffet Journal: J Clin Oncol Date: 2005-04-01 Impact factor: 44.544
Authors: Ann M Maddrey; Jon A Bergeron; Elizabeth R Lombardo; Noelle K McDonald; Arlynn F Mulne; Paul D Barenberg; Daniel C Bowers Journal: J Neurooncol Date: 2005-05 Impact factor: 4.130
Authors: Roger J Packer; James G Gurney; Judy A Punyko; Sarah S Donaldson; Peter D Inskip; Marilyn Stovall; Yutaka Yasui; Ann C Mertens; Charles A Sklar; H Stacy Nicholson; Lonnie K Zeltzer; Joseph P Neglia; Leslie L Robison Journal: J Clin Oncol Date: 2003-09-01 Impact factor: 50.717
Authors: Rosa Reed-Berendt; Bob Phillips; Susan Picton; Paul Chumas; Daniel Warren; John H Livingston; Ellen Hughes; Matthew C H J Morrall Journal: Childs Nerv Syst Date: 2014-01-23 Impact factor: 1.475
Authors: Fiona Schulte; Tara M Brinkman; Chenghong Li; Taryn Fay-McClymont; Deo Kumar Srivastava; Kirsten K Ness; Rebecca M Howell; Sabine Mueller; Elizabeth Wells; Douglas Strother; Lucie Lafay-Cousin; Wendy Leisenring; Leslie L Robison; Gregory T Armstrong; Kevin R Krull Journal: Cancer Date: 2018-08-01 Impact factor: 6.860
Authors: Tara M Brinkman; Chenghong Li; Kathryn Vannatta; Jordan G Marchak; Jin-Shei Lai; Pinki K Prasad; Cara Kimberg; Stefanie Vuotto; Chongzhi Di; Deokumar Srivastava; Leslie L Robison; Gregory T Armstrong; Kevin R Krull Journal: J Clin Oncol Date: 2016-07-18 Impact factor: 44.544
Authors: Matthew C Hocking; Mark McCurdy; Elise Turner; Anne E Kazak; Robert B Noll; Peter Phillips; Lamia P Barakat Journal: Pediatr Blood Cancer Date: 2014-11-08 Impact factor: 3.167
Authors: Ryan Wier; Holly A Aleksonis; Matthew M Pearson; Christopher J Cannistraci; Adam W Anderson; John F Kuttesch; Bruce E Compas; Kristen R Hoskinson Journal: J Neurooncol Date: 2019-05-09 Impact factor: 4.130
Authors: Victoria W Willard; Heather M Conklin; Frederick A Boop; Shengjie Wu; Thomas E Merchant Journal: Int J Radiat Oncol Biol Phys Date: 2014-01-22 Impact factor: 7.038